作者: Gerrit Klaerner , Lance Berman
DOI:
关键词:
摘要: The present invention generally relates to methods of treating hypertension (HTN) in patients need thereof wherein the patient optionally further suffers from chronic kidney disease (CKD) or Type II diabetes mellitus (T2DM). also hyperkalemia a thereof, CKD, T2DM HTN and are being treated with an effective amount renin-angiotensin-aldosterone system (RAAS) agent. is can comprise administering potassium-binding polymer lower patient's blood pressure and/or increase stabilize function.